CRP and COVID-19: A number of observational studies have provided promising results for anakinra in COVID-19 patients in terms of respiratory improvement, reduced need for invasive mechanical ventilation, and improved overall survival along with a rapid reduction in inflammatory markers (e.g. CRP), as compared to standard-of-care (SOC)78, 79, 80, 81, 82, 83 (Table 1).